Industry News
Ingredients, technology, hero products and brand moves in beauty — daily AI-curated briefs with sources cited.
Doctor Plant Debut Dendrobium Oligosaccharide at CAME
Doctor Plant launched its Dendrobium oligosaccharide at the 2026 CAME Expo. The ingredient has been registered with NMPA. Its patent enzyme technology promotes collagen synthesis, offering a sample of independent R&D for local brands.
Source:青眼情报VividEYE Launches Vascular Network Solution for Eye Contour
Vendor VividEYE™ introduces a comprehensive eye care solution based on organic apple mint leaf extract. It targets vascular and lymphatic networks to improve eye contour, holding COSMOS and NATRUE certifications.
Source:Cosmetics BusinessEthyl Macadamiate Reduces White Rub-in
Ethyl Macadamiate, a macadamia-derived ester, offers formulators a practical way to reduce visible whitening and soaping in creams, lotions, and sunscreens without rebuilding the full emulsion system.
Source:Cosmetics BusinessCosphatec Launches Two COSMOS and NATRUE Compliant Natural Panthenol Variants
German ingredient supplier Cosphatec has launched two 100% natural panthenol variants at 98% and 75% concentrations. Produced via corn biofermentation and certified to COSMOS and NATRUE standards, they open new formulation options for natural cosmetics.
Source:Cosmetics BusinessThe Ordinary Launches First PDRN Eye Cream, London Pop-Up Highlights New Ingredient
The Ordinary launched its first eye cream featuring vegan PDRN, a biotech-derived alternative to traditional sources. A London pop-up event coincided with the launch to educate consumers on the ingredient's science.
Source:Cosmetics BusinessNeutrogena Launches New-Gen BEMT Sunscreens After FDA Approval
FDA approved BEMT, the first new UV filter in 25 years. Neutrogena launched two new products with BEMT to improve comfort and daily wear.
Source:Cosmetics BusinessExosomes in skincare: breakthrough science or hype
At in-cosmetics Global, exosome products dominated discussions, with suppliers offering varying definitions. A senior R&D expert notes the lack of unified standards, urging brands to verify efficacy and safety beyond marketing buzz.
Source:Cosmetics Business